Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Merocilline Biopharmaceutical is a Chinese pharmaceutical company established in 2007 that specializes in the research, development, and large-scale production of antibiotic preparations. The company operates modern manufacturing facilities designed to EU standards, focusing on high-quality powder injections including cephalosporins and penicillins. Its commercial portfolio features over 40 products, notably Cefminox Sodium, Meropenem Sodium, and Alocillin Sodium, alongside non-antibiotic products like Lysine Aspirin. Headquartered in Haikou, the company serves the domestic Chinese market through a professional marketing network and academic promotion. Merocilline is recognized for its commitment to quality control and its role as a significant supplier of essential anti-infective medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiang Xiao-ying.